SI2051704T1 - Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi - Google Patents

Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi

Info

Publication number
SI2051704T1
SI2051704T1 SI200631362T SI200631362T SI2051704T1 SI 2051704 T1 SI2051704 T1 SI 2051704T1 SI 200631362 T SI200631362 T SI 200631362T SI 200631362 T SI200631362 T SI 200631362T SI 2051704 T1 SI2051704 T1 SI 2051704T1
Authority
SI
Slovenia
Prior art keywords
active ingredient
weight
water
meth
pharmaceutical composition
Prior art date
Application number
SI200631362T
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Hema Ravishankar
Shradda Bodinge
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of SI2051704T1 publication Critical patent/SI2051704T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
SI200631362T 2006-08-18 2006-09-21 Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi SI2051704T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1465CH2006 2006-08-18
PCT/EP2006/066583 WO2008019712A1 (de) 2006-08-18 2006-09-21 Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser
EP06793706A EP2051704B1 (de) 2006-08-18 2006-09-21 Pharmazeutische Zusammensetzung mit kontrollierter Wirkstoffabgabe für Wirkstoffe mit guter Löslichkeit in Wasser

Publications (1)

Publication Number Publication Date
SI2051704T1 true SI2051704T1 (sl) 2012-08-31

Family

ID=37872157

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631362T SI2051704T1 (sl) 2006-08-18 2006-09-21 Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi

Country Status (14)

Country Link
US (1) US8465769B2 (sl)
EP (1) EP2051704B1 (sl)
JP (1) JP5661281B2 (sl)
KR (2) KR101556797B1 (sl)
CN (1) CN101484147B (sl)
AT (1) ATE553754T1 (sl)
BR (1) BRPI0621996B8 (sl)
CA (1) CA2661561C (sl)
ES (1) ES2385498T3 (sl)
IL (1) IL195407A (sl)
MX (1) MX2009001597A (sl)
PL (1) PL2051704T3 (sl)
SI (1) SI2051704T1 (sl)
WO (1) WO2008019712A1 (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005007059A1 (de) * 2005-02-15 2006-08-24 Röhm GmbH & Co. KG Teilneutralisiertes anionisches (Meth)acrylat-Copolymer
DE102005032806A1 (de) * 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
DE102006035549A1 (de) 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
DE102007009243A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
US9597293B2 (en) 2007-05-07 2017-03-21 Evonik Röhm Gmbh Solid dosage forms comprising an enteric coating with accelerated drug release
TR201902212T4 (tr) * 2008-01-10 2019-06-21 Evonik Roehm Gmbh Geli̇şmi̇ş deği̇şken dozlu akti̇f madde salimina sahi̇p kapli farmasöti̇k veya nutrasöti̇k preparat
US9237760B2 (en) * 2008-01-10 2016-01-19 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
EP2231122A1 (en) * 2008-01-10 2010-09-29 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
WO2009151594A1 (en) * 2008-06-10 2009-12-17 Teva Pharmaceutical Industries, Ltd. Rasagiline soft gelatin capsules
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
CA2729015A1 (en) * 2008-06-26 2009-12-30 Mcneil-Ppc, Inc. Coated particles containing pharmaceutically active agents
EP2359814A1 (en) * 2010-02-11 2011-08-24 Laboratorios Liconsa, S.A. Pharmaceutical mini-tablets for sustained release of flecainide acetate
US20120301541A1 (en) * 2011-05-24 2012-11-29 Haronsky Elina Compressed core for pharmaceutical composition
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
MX2015012970A (es) 2013-03-14 2016-04-11 Redhill Biopharma Ltd Formas de dosificacion solidas de liberacion prolongada antiemeticas.
MX2016011734A (es) * 2014-03-11 2017-02-13 Redhill Biopharma Ltd Formas de dosificacion sólida de liberación extendida de onndasetrón para trtar bien sea síntomas de náusea, vómito o diarrea.
US9580896B2 (en) 2014-07-05 2017-02-28 John David Hopkins Apparatus and method for prolonged active agent in aqueous systems
US10799138B2 (en) 2018-04-05 2020-10-13 University Of Maryland, Baltimore Method of administering sotalol IV/switch
BR112020023983A2 (pt) 2018-05-24 2021-02-23 Celanese Eva Performance Polymers Llc dispositivo implantável para liberação prolongada de um composto de fármaco macromolecular
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
JP2002534374A (ja) * 1999-01-07 2002-10-15 エラン コーポレーシヨン ピーエルシー 多粒子経口用量形態
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
US20060183767A1 (en) * 2003-01-06 2006-08-17 Eugene Mandrea Methods of stimulating immune response in certain individuals
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
TW200626185A (en) * 2004-12-17 2006-08-01 Bpsi Holdings Inc Enteric film coating composition containing entericpolymer micronized with detackifier
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander

Also Published As

Publication number Publication date
CN101484147A (zh) 2009-07-15
US8465769B2 (en) 2013-06-18
MX2009001597A (es) 2009-02-23
PL2051704T3 (pl) 2012-09-28
CA2661561A1 (en) 2008-02-21
IL195407A (en) 2013-05-30
KR101556797B1 (ko) 2015-10-01
ES2385498T3 (es) 2012-07-25
CN101484147B (zh) 2015-07-08
CA2661561C (en) 2013-12-24
IL195407A0 (en) 2009-08-03
BRPI0621996B1 (pt) 2020-07-14
JP2010501015A (ja) 2010-01-14
ATE553754T1 (de) 2012-05-15
BRPI0621996A2 (pt) 2011-12-27
US20080044470A1 (en) 2008-02-21
KR20140019038A (ko) 2014-02-13
WO2008019712A1 (de) 2008-02-21
EP2051704B1 (de) 2012-04-18
BRPI0621996B8 (pt) 2022-07-05
KR20090042922A (ko) 2009-05-04
EP2051704A1 (de) 2009-04-29
JP5661281B2 (ja) 2015-01-28

Similar Documents

Publication Publication Date Title
IL195407A0 (en) Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water
WO2000019984A3 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
WO2007006353A3 (de) Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten
MXPA04003970A (es) Granulos o polvo para la produccion de agentes de recubrimiento y aglutinantes para formas farmaceuticas.
IL167334A (en) Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
IL175561A0 (en) Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения
BRPI0610206B8 (pt) uso de misturas de polímeros para a produção de formulações farmacêuticas revestidas, e formulação farmacêutica com revestimento polimérico misto
NZ572760A (en) A delayed release drug formulation comprising a coating comprising a low amylose starch and a Eudragit acrylate polymer
CA2338750A1 (en) Coating and binding agent for oral or dermal pharmaceutical forms
IL180849A0 (en) Medicament in a multilayer form
EP1048676A3 (en) Polymer compositions
DE59907676D1 (de) Wässrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
PL2178927T3 (pl) Proces tworzenia mieszaniny zawierającej kationowy oligomer winylu
WO2011045775A4 (en) A delayed release pharmaceutical composition of mesalamine
MX2010007578A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.
MX340057B (es) Composicion en polvo o granulada que consta de un copolimero, un acido dicarboxilico y un acido graso monocarboxilico.
MX2010007579A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
WO2006007999A3 (en) Aqueous vinyl graft copolymer compositions
MX2021010914A (es) Forma de dosificacion que comprende una matriz polimerica.